FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16756411000001100: Powder and solvent for suspension for infusion (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58830501000001117 Powder and solvent for suspension for infusion (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58830601000001118 Powder and solvent for suspension for infusion en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder and solvent for suspension for infusion Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder and solvent for suspension for infusion Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Powder and solvent for suspension for infusion Has dose form administration method Infuse true Inferred relationship Existential restriction modifier
Powder and solvent for suspension for infusion Is a Infusion powder false Inferred relationship Existential restriction modifier
Powder and solvent for suspension for infusion Is a Parenteral dose form true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials Has dispensed dose form True Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Factor VIII Inhibitor Bypassing Fraction human 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials Has dispensed dose form False Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
FEIBA 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials (Takeda UK Ltd) Has dispensed dose form False Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Factor VIII Inhibitor Bypassing Fraction human 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials 1 vial Has dispensed dose form False Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
FEIBA 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form False Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has dispensed dose form True Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials 2 vial Has dispensed dose form True Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) 2 vial Has dispensed dose form True Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Doxorubicin (liposomal) 50mg powder and solvent for suspension for injection vials Has manufactured dose form False Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier
Myocet 50mg powder and solvent for suspension for injection vials (Zeneus Pharma) Has manufactured dose form True Powder and solvent for suspension for infusion Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start